SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 15, 1995
THE DOW CHEMICAL COMPANY
(Exact name of registrant as specified in its charter)
Delaware 1-3433 38-1285128
(State or other jurisdiction (Commission File (IRS Employer
of incorporation) Number) Identification No.)
2030 Dow Center, Midland, Michigan 48674
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (517) 636-1000
Not applicable
(Former name or former address, if changed since last report.)
Page 1 of 3
Item 5. Other Events
The Dow Chemical Company issued a press release on May 15, 1995, the
text of which is as follows:
FOR FURTHER INFORMATION:
The Dow Chemical Company
2030 Dow Center
Midland, MI 48674
517-636-1940
May 15, 1995
DOW CORNING ACTION TO RESULT IN CHARGE
AGAINST EARNINGS FOR DOW CHEMICAL
Dow Corning Corporation today announced that it has
voluntarily filed for protection under Chapter 11 of the
United States Bankruptcy Code with the United States
Bankruptcy Court in Bay City, Michigan.
As a result of this action, The Dow Chemical Company, a 50
percent shareholder in Dow Corning, has decided to establish
a reserve for the full amount of its investment of $374
million and to discontinue recording any proportional share
of future equity earnings. The charge will impact Dow
Chemical's second quarter of 1995 earnings by approximately
$1.25 per share.
"As one of two shareholders in Dow Corning, it is our
understanding that this was the only viable alternative
under today's existing tort system to resolve the thousands
of breast implant lawsuits pending against Dow Corning,"
said Enrique C. Falla, executive vice president. "We are
disappointed that Dow Corning was required to take this
action despite substantial research that has not shown a
link between breast implants and the diseases alleged in
lawsuits."
Page 2 of 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly
authorized.
THE DOW CHEMICAL COMPANY
Registrant
/s/Enrique C. Falla
Enrique C. Falla
Executive Vice President and
Chief Financial Officer
Date: May 15, 1995
Page 3 of 3
